The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Johnson & Johnson shares valued at $1,441,765 were sold by Broadhurst Vanessa on Mar 13 ’24. At $162.16 per share, Broadhurst Vanessa sold 8,891 shares. The insider’s holdings dropped to 15,043 shares worth approximately $2.25 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, JOHNSON & JOHNSON sold 3,725 shares, netting a total of over 96,142 in proceeds. Following the sale of shares at $25.81 each, the insider now holds 4,099,575 shares.
Before that, Taubert Jennifer L had sold 59,397 shares from its account. In a trade valued at $9,281,969, the EVP, WW Chair, Pharmaceuticals traded Johnson & Johnson shares for $156.27 each. Upon closing the transaction, the insider’s holdings decreased to 59,397 shares, worth approximately $21.17 million.
As published in a research note from HSBC Securities on April 18, 2024, Johnson & Johnson [JNJ] has been rated up from a Hold to a Buy and the price target has been revised to $170. Analysts at Wells Fargo downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in mid December. As of December 01, 2023, UBS has increased its “Neutral” rating to a “Buy” for JNJ. Earlier on October 05, 2023, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for JNJ stock.
Analyzing JNJ Stock Performance
During the last five days, there has been a drop of approximately -2.97%. Over the course of the year, Johnson & Johnson shares have dropped approximately -4.49%. Shares of the company reached a 52-week high of $163.58 on 01/22/24 and a 52-week low of $143.13 on 04/18/24. A 50-day SMA is recorded $151.55, while a 200-day SMA reached $156.52. Nevertheless, trading volume fell to 7.42 million shares from 6.61 million shares the previous day.
Support And Resistance Levels for Johnson & Johnson (JNJ)
According to the 24-hour chart, there is a support level at 148.44, which, if violated, would cause prices to drop to 147.17. In the upper region, resistance lies at 151.90. The next price resistance is at 154.10. RSI (Relative Strength Index) is 46.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.34, which suggests the price will decrease in the coming days. Percent R is at 74.24%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
